Susunod

Auto-play

The Impact and Long-Term Potential of Olaratumab in Soft Tissue Sarcoma

2 Mga view • 07/18/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Symantha Melemed, PhD, global product team lead, Oncology Business Unit, Eli Lilly & Company, discusses the impact of the FDA approval of olaratumab (Lartruvo) and its long-term potential in the field of sarcoma.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play